A carregar...
Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments
BACKGROUND: An aerosol foam formulation of fixed combination calcipotriol 50 μg/g (Cal) and betamethasone 0.5 mg/g (as dipropionate; BD) has been developed for psoriasis vulgaris treatment. OBJECTIVE: To compare Cal/BD aerosol foam pharmacodynamic activity with Cal/BD ointment and with other topical...
Na minha lista:
| Publicado no: | J Eur Acad Dermatol Venereol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5108427/ https://ncbi.nlm.nih.gov/pubmed/27306589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdv.13714 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|